中国实用儿科杂志2024，Vol.39Issue(8)：561-566,6.DOI:10.19538/j.ek2024080601
《欧洲儿科胃肠病学、肝病学和营养学学会关于益生菌治疗儿童胃肠道疾病的立场文件》解读
Interpretation of Probiotics for the Management of Pediatric Gastrointestinal Disorders:Position Paper of ESPGHAN
摘要
Abstract
The gut microbiome plays a critical role in human health,and probiotics are one of the important and effective interventions targeting the gut microbiome.In recent years,the European Society for Paediatric Gastroenterology,Hepatology and Nutrition(ESPGHAN)Working Group published several clinical guidelines on the use of probiotics for preventing or treating gastrointestinal disorders in children.The 2022 edition of the ESPGHAN Position Paper on Probiotics for the Management of Pediatric Gastrointestinal Disorders updates and complements the indications contained in the earlier guidelines,providing the most comprehensive recommendations for the use of probiotics in pediatric gastrointestinal disorders.On the basis of the interpretation of this position paper,this article takes the situationin China into consideration,with a view to guiding pediatricians in their clinical decision-making.关键词
益生菌/胃肠道疾病/儿童/立场文件Key words
probiotics/gastrointestinal disorder/child/position papers分类
医药卫生引用本文复制引用
吕垚,甄长君,陈洁..《欧洲儿科胃肠病学、肝病学和营养学学会关于益生菌治疗儿童胃肠道疾病的立场文件》解读[J].中国实用儿科杂志,2024,39(8):561-566,6.基金项目
浙江省自然科学基金(LQ22H160006) （LQ22H160006）
